Sue Hughes

Thrombectomy Choice in Basilar Stroke May Hinge on Clot Type

‘Designer Drug’ Shows Early Neuroprotective Signal in Acute Ischemic Stroke

In patients with cardiovascular disease who had an ICD and were at high risk for ventricular arrhythmias, increasing potassium levels led to a significantly lower risk for arrhythmia events.

A new algorithm, tested via computer modeling across the continental United States, more accurately routes patients with stroke to EVT centers, boosting functional outcomes.

The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a practice-changing trial, according to experts.

Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to show a benefit in three new randomized trials.

For patients with diabetes, a systolic target of 120 mm Hg led to a significant reduction in CV events in BPROADS, mirroring results from SPRINT in patients without diabetes.

SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart failure and a preserved ejection fraction and obesity.

With growing evidence that loneliness increases the risk for multiple diseases, there are questions about the mechanisms at play and what clinicians can do to help patients.

Thrombolysis Beneficial for ‘Eye Stroke’?

Extending the simple CT scan administered to all acute stroke patients to include the upper part of the heart increased cardioaortic thrombus detection by almost sixfold.

The long-standing debate as to when to start anticoagulation in patients with an acute ischemic stroke and atrial fibrillation looks as though it is settled.

Evidence is rising in favor of using highly effective DMTs to treat pediatric MS, but with few licensed for pediatric use, it may be time to rethink the standard treatment approach.

Single-pill combinations of three or more antihypertensive drugs are the way forward to help patients reach lower blood pressure targets, according to experts evaluating the approach.

Results of the HELIOS-B trial indicate patients may soon have a second drug class available to slow the progression of transthyretin-mediated amyloidosis with cardiomyopathy, a fatal disease.

It does not matter whether antihypertensive medication is taken in the morning or at bedtime, two new trials confirm.

The long-debated question of whether mineralocorticoid receptor antagonists are effective for heart failure with mildly reduced or preserved ejection fraction has been answered in a new trial.

Simplified and more aggressive targets are among the significant changes to the updated hypertension guidelines by the European Society of Cardiology.

A new trial is calling into question recent recommendations to discontinue beta-blocker treatment in patients with myocardial infarction and preserved left ventricular function.

A new study showed a newer recombinant shingles vaccine was linked to a 164-day delay in dementia diagnosis in older adults compared to an older live shingles vaccine.